Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

…, JE Kenison, L Mayo, CC Chao, B Patel… - Nature medicine, 2016 - nature.com
Astrocytes have important roles in the central nervous system (CNS) during health and
disease. Through genome-wide analyses we detected a transcriptional response to type I …

[HTML][HTML] Alterations of the human gut microbiome in multiple sclerosis

…, LM Cox, N Li, F Von Glehn, R Yan, B Patel… - Nature …, 2016 - nature.com
The gut microbiome plays an important role in immune function and has been implicated in
several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut …

[PDF][PDF] Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses

N Joller, E Lozano, PR Burkett, B Patel, S Xiao, C Zhu… - Immunity, 2014 - cell.com
Foxp3 + T regulatory (Treg) cells regulate immune responses and maintain self-tolerance.
Recent work shows that Treg cells are comprised of many subpopulations with specialized …

Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α

ID Mascanfroni, MC Takenaka, A Yeste, B Patel… - Nature medicine, 2015 - nature.com
Our understanding of the pathways that regulate lymphocyte metabolism, as well as the
effects of metabolism and its products on the immune response, is still limited. We report that a …

Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation

L Mayo, SA Trauger, M Blain, M Nadeau, B Patel… - Nature medicine, 2014 - nature.com
Astrocytes have complex roles in health and disease, thus it is important to study the pathways
that regulate their function. Here we report that lactosylceramide (LacCer) synthesized by …

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39

…, A Yeste, SM Vieira, EJ Burns, B Patel… - Nature …, 2013 - nature.com
Dendritic cells (DCs) control the balance between effector T cells and regulatory T cells in
vivo. Hence, the study of DCs might identify mechanisms of disease pathogenesis and guide …

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis

…, A Musallam, MS Hussain, P Nejad, B Patel… - Annals of …, 2013 - Wiley Online Library
Objective MicroRNAs (miRNAs) are single‐stranded, small noncoding RNAs that regulate
gene expression. Because they are stable in serum, they are being developed as biomarkers …

[PDF][PDF] Melatonin contributes to the seasonality of multiple sclerosis relapses

…, G Murugaiyan, LP Garo, MEB Aguirre, B Patel… - Cell, 2015 - cell.com
Seasonal changes in disease activity have been observed in multiple sclerosis, an
autoimmune disorder that affects the CNS. These epidemiological observations suggest that …

Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2

…, ID Mascanfroni, M Nadeau, JE Kenison, B Patel… - Science …, 2016 - science.org
Type 1 diabetes (T1D) is a T cell–dependent autoimmune disease that is characterized by
the destruction of insulin-producing β cells in the pancreas. The administration to patients of …

[PDF][PDF] AHR activation is protective against colitis driven by T cells in humanized mice

…, S Sambanthamoorthy, AE Griffith, B Patel… - Cell reports, 2016 - cell.com
Existing therapies for inflammatory bowel disease that are based on broad suppression of
inflammation result in variable clinical benefit and unwanted side effects. A potential …